Team
- Home
- Team
Team
Our diverse, highly experienced global team is a core strength and differentiator, with expertise spanning science, medicine, commercial strategy, operations, and leadership, enabling us to drive innovation across all aspects of our portfolio

Michael Yu
Managing Partner and Founder

Michael Yu
Managing Partner and Founder
Michael is a seasoned investor and entrepreneur with a deep track record in biotech and life sciences. As Managing Partner and Founder of Stratos BioCapital, he is committed to identifying breakthrough innovations and supporting visionary entrepreneurs in building transformative healthcare companies.
Before Stratos BioCapital, Michael was a founding partner at multiple successful investment firms, where he led strategic investments in pioneering biotech ventures. With a background spanning venture capital, company building, and operational leadership, he brings a wealth of experience in scaling disruptive technologies from early-stage development to global impact.

Maria Lopez
Chief Legal Officer

Maria Lopez
Chief Legal Officer
Maria is the Chief Legal Officer at Stratos BioCapital, where she oversees all legal and regulatory aspects of the firm’s investments and portfolio operations. With extensive experience in biotech transactions, corporate governance, and risk management, she plays a critical role in structuring deals and guiding companies through complex regulatory frameworks.
Prior to joining Stratos BioCapital, Maria was a partner at Wilson Sonsini, where she advised top life sciences companies and investors on mergers, acquisitions, and venture financings. She holds an LLM from Columbia Law School and an LLB from the University of Toronto, bringing a global perspective to biotech dealmaking and innovation.

Nick Tan
Partner

Nick Tan
Partner
Nick is a Partner at Stratos BioCapital, bringing decades of leadership experience in biotech investment, company building, and immunology-driven innovation. With a strong track record of guiding biotech ventures from early-stage development to commercialization, he plays a pivotal role in identifying and supporting transformative healthcare opportunities.
Prior to joining Stratos BioCapital, Nick was the CEO of BioRay Therapeutics and served as Chairman of Sino ImmunoTech and Genomics Frontier. He was also Managing Director at HuaTai Bioventures, where he led investments in cutting-edge life sciences companies.
Nick earned his PhD in Immunology from Fudan University and completed his postdoctoral research in cancer immunology at National Taiwan University. His deep scientific expertise and strategic vision make him a key leader in advancing breakthrough biotech innovations.

Rahul Dev
Partner

Rahul Dev
Partner
Rahul is a Partner at Stratos BioCapital, bringing extensive experience in biotech entrepreneurship, investment banking, and business development across the Asia-Pacific region. With a strong background in life sciences and capital markets, he plays a key role in identifying and supporting innovative biotech ventures.
Prior to joining Stratos BioCapital, Rahul was the CEO and Founder of BioVance Therapeutics. He previously served as Head of Healthcare Investments at Temasek Holdings and was Regional Business Development Director for Asia-Pacific at Zuellig Pharma. He has also held academic roles as an Associate Professor at the Yong Loo Lin School of Medicine, National University of Singapore.
Rahul earned his PhD and MA in Molecular Biology from the National University of Singapore and an MBA from Nanyang Business School. His leadership and deep industry expertise drive Stratos BioCapital’s mission to accelerate biotech innovation.

Paul Lightfoot
Partner

Paul Lightfoot
Partner
Paul is a Partner at Stratos BioCapital, bringing extensive experience in biotech investment, corporate strategy, and business development. With a strong background in venture capital and life sciences, he plays a key role in identifying and supporting high-potential biotech companies.
Prior to joining Stratos BioCapital, Paul was a Director at Versant Ventures. He previously held leadership roles at Medtronic and Zymeworks, where he focused on strategic partnerships and market expansion.
Paul earned his MBA from the University of Toronto, an M.A. in Biotechnology from McGill University, and a B.S. in Biochemistry from the University of Washington. His expertise in global biotech investments and commercialization drives Stratos BioCapital’s mission to advance breakthrough healthcare solutions.

Ricardo Gonzalez
Partner

Ricardo Gonzalez
Partner
Ricardo is a Partner at Stratos BioCapital, bringing extensive experience in biotech investment, venture capital, and corporate strategy. With a strong background in life sciences and healthcare financing, he plays a key role in identifying and supporting groundbreaking biotech innovations.
Prior to joining Stratos BioCapital, Ricardo was a Partner at Alta Life Sciences and previously served as Co-Head of Pharma & Biotech at Ysios Capital. He was also a Principal at Asabys Partners, where he focused on early- and growth-stage biotech investments.
Ricardo earned his BA in Biochemistry from the University of Barcelona, his MD from the University of Navarra, and his MBA from IESE Business School. His expertise in global biotech investments and company building supports Stratos BioCapital’s mission to accelerate transformative healthcare solutions.